Literature DB >> 16314117

Reappraisal of the Hansemann-Boveri hypothesis on the origin of tumors.

Paul A Hardy1, Helmut Zacharias.   

Abstract

Cancer is now known to be a genetic disease. In tumor development, cell nuclei undergo mutations, which can result in cytologically visible chromosome aberrations. The aneuploid errors may involve amplification or deletion of whole chromosomes or segments thereof. David Hansemann [1858-1920] and Theodor Boveri [1862-1915] were major contributors to early debates on the relationship between chromosomal defects, tumorigenesis and malignancies. In 1890, Hansemann observed asymmetrical nuclear divisions in human epithelial cancers. In these abnormal, but bipolar, divisions, a fraction of the chromosomes fails to segregate properly. Hansemann carefully documented the occurrence of asymmetric divisions in a wide variety of tumors. However, he remained a lifelong skeptic with regard to whether such events could be considered the underlying cause of tumors. Almost a quarter of a century after Hansemann's initial observations, Boveri considered the origin of tumors based on his earlier recognition of the functional specificity of each chromosome. He also explicitly drew on Hansemann's observations in proposing a model for tumorigenesis. Its central tenet was that a tumor typically originates from a single cell that has inherited a defined, but incorrectly combined, set of chromosomes. The rare occurrence of a pluripolar spindle represented Boveri's paradigm for a type of abnormal mitosis that can produce a host of random chromosomal combinations. He suggested that some of these combinations will induce tumorous transformation, and will inevitably arise occasionally. Since pluripolar and unbalanced bipolar divisions fail to distribute the hereditary chromatic material correctly, both of these mechanisms can give rise to tumor progenitors.

Entities:  

Mesh:

Year:  2005        PMID: 16314117     DOI: 10.1016/j.cellbi.2005.10.001

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   3.612


  24 in total

Review 1.  The Janus soul of centrosomes: a paradoxical role in disease?

Authors:  Maddalena Nano; Renata Basto
Journal:  Chromosome Res       Date:  2016-01       Impact factor: 5.239

Review 2.  Mitosis as an anti-cancer drug target.

Authors:  Anna-Leena Salmela; Marko J Kallio
Journal:  Chromosoma       Date:  2013-06-18       Impact factor: 4.316

Review 3.  Mitotic catastrophe: a mechanism for avoiding genomic instability.

Authors:  Ilio Vitale; Lorenzo Galluzzi; Maria Castedo; Guido Kroemer
Journal:  Nat Rev Mol Cell Biol       Date:  2011-04-29       Impact factor: 94.444

Review 4.  New insights into the troubles of aneuploidy.

Authors:  Jake J Siegel; Angelika Amon
Journal:  Annu Rev Cell Dev Biol       Date:  2012-07-09       Impact factor: 13.827

Review 5.  Mitotic spindle multipolarity without centrosome amplification.

Authors:  Helder Maiato; Elsa Logarinho
Journal:  Nat Cell Biol       Date:  2014-05       Impact factor: 28.824

Review 6.  Causes and consequences of centrosome abnormalities in cancer.

Authors:  S A Godinho; D Pellman
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-09-05       Impact factor: 6.237

Review 7.  The centrosome cycle: Centriole biogenesis, duplication and inherent asymmetries.

Authors:  Erich A Nigg; Tim Stearns
Journal:  Nat Cell Biol       Date:  2011-10-03       Impact factor: 28.824

8.  Anti-centrosome antibodies in breast cancer are the expression of autoimmunity.

Authors:  Marie-Claire Maroun; Ofelia Olivero; Leonard Lipovich; Azadeh Stark; Larry Tait; Sudeshna Bandyopadhyay; Matthew Burke; Richard Zarbo; Dhananjay Chitale; S David Nathanson; Mike Long; Carol Peebles; Félix Fernández Madrid
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829

Review 9.  Gene dysregulations driven by somatic copy number aberrations-biological and clinical implications in colon tumors: a paper from the 2009 William Beaumont Hospital Symposium on Molecular Pathology.

Authors:  Manny D Bacolod; Francis Barany
Journal:  J Mol Diagn       Date:  2010-08-13       Impact factor: 5.568

Review 10.  Drosophila melanogaster: a model and a tool to investigate malignancy and identify new therapeutics.

Authors:  Cayetano Gonzalez
Journal:  Nat Rev Cancer       Date:  2013-02-07       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.